ABBVIE ANNOUNCES HIGH SUSTAINED VIROLOGIC RESPONSE RATES IN PHASE 2 STUDIES WITH PAN-GENOTYPIC, INVESTIGATIONAL REGIMEN IN PATIENTS WITH CHRONIC HEPATITIS C

Press/Media: Press / Media

PeriodNov 20 2015

Media coverage

1

Media coverage

  • TitleABBVIE ANNOUNCES HIGH SUSTAINED VIROLOGIC RESPONSE RATES IN PHASE 2 STUDIES WITH PAN-GENOTYPIC, INVESTIGATIONAL REGIMEN IN PATIENTS WITH CHRONIC HEPATITIS C
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date11/20/15
    PersonsFred Poordad